Skip to content
DataLookout
Menu

NCT07171710

Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

The Ocular Surface Disease Index (OSDI) score
Timeframe: Assessed after 3 months of the trial
VAS score
Timeframe: Assessed after 3 months of the trial
BUT
Timeframe: Assessed after 6 months of the trial
tear river height
Timeframe: Assessed after 6 months of the trial
IVCM examination
Timeframe: Assessed after 6 months of the trial

Arms and interventions

Experimental groupOther

One eye was randomized to recieve a Smart plug absorbable lacrimal duct plugs, and cyclosporin A 0.05% cyclosporine A eye drops were administered three times daily to both eyes.

Control groupOther

cyclosporin A 0.05% cyclosporine A eye drops were administered three times daily to both eyes.

Drugs: 0.05% Cyclosporine Eye Drops

Devices: Smart plug absorbable lacrimal duct plugs

Sites

1 site in 1 country

  • Tianjin Eye HospitalTianjin, Tianjin Municipality, China